General information about company |
|||
---|---|---|---|
Scrip Code | 524774 | ||
NSE Symbol | NGLFINE | ||
MSEI Symbol | NOTLISTED | ||
ISIN | INE887E01022 | ||
Name of company | NGL FINE-CHEM LIMITED | ||
Type of company | Main Board | ||
Class of security | Equity | ||
Date of start of financial year | 01-Apr-2024 | ||
Date of end of financial year | 31-Mar-2025 | ||
Date of board meeting when results were approved | 22-May-2025 | ||
Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 05-May-2025 | ||
Description of presentation currency | INR (in Actuals) | ||
Reporting Type | Quarterly | ||
Reporting Quarter | Fourth quarter | ||
Nature of report standalone or consolidated | Consolidated | ||
Whether results are audited or unaudited for the quarter ended | Audited | ||
Whether results are audited or unaudited for the Year to date for current period ended/year ended | Audited | ||
Segment Reporting | Single segment | ||
Description of single segment | PHARMACEUTICALS | ||
Start date and time of board meeting | 22-May-2025 18:00:00 | ||
End date and time of board meeting | 22-May-2025 19:10:00 | ||
Whether cash flow statement is applicable on company | Yes | ||
Type of cash flow statement | Cash Flow Indirect | ||
Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
Financial Results Ind-AS |
|||
---|---|---|---|
Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
A | Date of start of reporting period | 01-Jan-2025 | 01-Apr-2024 |
B | Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 |
C | Whether results are audited or unaudited | Audited | Audited |
D | Nature of report standalone or consolidated | Consolidated | Consolidated |
Part I | Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column. | ||
1 | Income | ||
Revenue from operations | 949714000 | 3682567000 | |
Other income | -9656000 | 86304000 | |
Total income | 940058000 | 3768871000 | |
2 | Expenses | ||
(a) | Cost of materials consumed | 511816000 | 1824125000 |
(b) | Purchases of stock-in-trade | 0 | 0 |
(c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | -33793000 | -59000 |
(d) | Employee benefit expense | 142474000 | 555461000 |
(e) | Finance costs | 9736000 | 23341000 |
(f) | Depreciation, depletion and amortisation expense | 33204000 | 124511000 |
(f) | Other Expenses | ||
1 | Other Expenses | 266019000 | 964349000 |
Total other expenses | 266019000 | 964349000 | |
Total expenses | 929456000 | 3491728000 | |
3 | Total profit before exceptional items and tax | 10602000 | 277143000 |
4 | Exceptional items | 0 | 0 |
5 | Total profit before tax | 10602000 | 277143000 |
6 | Tax expense | ||
7 | Current tax | 1008000 | 62270000 |
8 | Deferred tax | 4157000 | 3630000 |
9 | Total tax expenses | 5165000 | 65900000 |
10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0 | 0 |
11 | Net Profit Loss for the period from continuing operations | 5437000 | 211243000 |
12 | Profit (loss) from discontinued operations before tax | 0 | 0 |
13 | Tax expense of discontinued operations | 0 | 0 |
14 | Net profit (loss) from discontinued operation after tax | 0 | 0 |
15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0 | 0 |
16 | Total profit (loss) for period | 5437000 | 211243000 |
17 | Other comprehensive income net of taxes | -114000 | -2404000 |
18 | Total Comprehensive Income for the period | 5323000 | 208839000 |
19 | Total profit or loss, attributable to | ||
Profit or loss, attributable to owners of parent | |||
Total profit or loss, attributable to non-controlling interests | |||
20 | Total Comprehensive income for the period attributable to | ||
Comprehensive income for the period attributable to owners of parent | |||
Total comprehensive income for the period attributable to owners of parent non-controlling interests | |||
21 | Details of equity share capital | ||
Paid-up equity share capital | 30890000 | 30890000 | |
Face value of equity share capital | 5 | 5 | |
27 | Details of debt securities | ||
22 | Reserves excluding revaluation reserve | 2765244000 | |
23 | Earnings per share | ||
i | Earnings per equity share for continuing operations | ||
Basic earnings (loss) per share from continuing operations | 0.88 | 34.19 | |
Diluted earnings (loss) per share from continuing operations | 0.88 | 34.19 | |
ii | Earnings per equity share for discontinued operations | ||
Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
ii | Earnings per equity share | ||
Basic earnings (loss) per share from continuing and discontinued operations | 0.88 | 34.19 | |
Diluted earnings (loss) per share from continuing and discontinued operations | 0.88 | 34.19 | |
24 | Debt equity ratio | ||
25 | Debt service coverage ratio | ||
26 | Interest service coverage ratio | ||
27 | Disclosure of notes on financial results |
Remarks |
|
---|---|
Debt equity ratio | |
Debt service coverage ratio | |
Interest service coverage ratio |
Statement of Asset and Liabilities |
|||
---|---|---|---|
Particulars | Year ended (dd-mm-yyyy) | ||
Date of start of reporting period | 01-Apr-2024 | ||
Date of end of reporting period | 31-Mar-2025 | ||
Whether results are audited or unaudited | Audited | ||
Nature of report standalone or consolidated | Consolidated | ||
Assets | |||
1 | Non-current assets | ||
Property, plant and equipment | 1421212000 | ||
Capital work-in-progress | 497258000 | ||
Investment property | |||
Goodwill | 0 | ||
Other intangible assets | 5499000 | ||
Intangible assets under development | |||
Biological assets other than bearer plants | |||
Investments accounted for using equity method | |||
Non-current financial assets | |||
Non-current investments | 0 | ||
Trade receivables, non-current | |||
Loans, non-current | 0 | ||
Other non-current financial assets | 10000000 | ||
Total non-current financial assets | 10000000 | ||
Deferred tax assets (net) | |||
Other non-current assets | 46151000 | ||
Total non-current assets | 1980120000 | ||
2 | Current assets | ||
Inventories | 512700000 | ||
Current financial asset | |||
Current investments | 596637000 | ||
Trade receivables, current | 815508000 | ||
Cash and cash equivalents | 5833000 | ||
Bank balance other than cash and cash equivalents | 52809000 | ||
Loans, current | 0 | ||
Other current financial assets | 83864000 | ||
Total current financial assets | 1554651000 | ||
Current tax assets (net) | |||
Other current assets | 286442000 | ||
Total current assets | 2353793000 | ||
3 | Non-current assets classified as held for sale | ||
4 | Regulatory deferral account debit balances and related deferred tax Assets | ||
Total assets | 4333913000 | ||
Equity and liabilities | |||
1 | Equity | ||
Equity attributable to owners of parent | |||
Equity share capital | 30890000 | ||
Other equity | 2793456000 | ||
Total equity attributable to owners of parent | 2824346000 | ||
Non controlling interest | |||
Total equity | 2824346000 | ||
2 | Liabilities | ||
Non-current liabilities | |||
Non-current financial liabilities | |||
Borrowings, non-current | 253357000 | ||
Trade payables, non-current | |||
(A) Total outstanding dues of micro enterprises and small enterprises | |||
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises | |||
Total Trade payable | |||
Other non-current financial liabilities | |||
Total non-current financial liabilities | 253357000 | ||
Provisions, non-current | 40013000 | ||
Deferred tax liabilities (net) | 24762000 | ||
Deferred government grants, Non-current | |||
Other non-current liabilities | 1735000 | ||
Total non-current liabilities | 319867000 | ||
Current liabilities | |||
Current financial liabilities | |||
Borrowings, current | 478177000 | ||
Trade payables, current | |||
(A) Total outstanding dues of micro enterprises and small enterprises | 0 | ||
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 575180000 | ||
Total Trade payable | 575180000 | ||
Other current financial liabilities | 121541000 | ||
Total current financial liabilities | 1174898000 | ||
Other current liabilities | |||
Provisions, current | 14802000 | ||
Current tax liabilities (Net) | |||
Deferred government grants, Current | |||
Total current liabilities | 1189700000 | ||
3 | Liabilities directly associated with assets in disposal group classified as held for sale | ||
4 | Regulatory deferral account credit balances and related deferred tax liability | ||
Total liabilities | 1509567000 | ||
Total equity and liabilites | 4333913000 | ||
Disclosure of notes on assets and liabilities |
Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results |
|||||||
---|---|---|---|---|---|---|---|
Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
Date of start of reporting period | 01-Jan-2025 | 01-Apr-2024 | |||||
Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 | |||||
Whether accounts are audited or unaudited | Audited | Audited | |||||
Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
1 | Segment Revenue (Income) | ||||||
(net sale/income from each segment should be disclosed) | |||||||
Total Segment Revenue | |||||||
Less: Inter segment revenue | |||||||
Revenue from operations | |||||||
2 | Segment Result | ||||||
Profit (+) / Loss (-) before tax and interest from each segment | |||||||
Total Profit before tax | |||||||
i. Finance cost | |||||||
ii. Other Unallocable Expenditure net off Unallocable income | |||||||
Profit before tax | |||||||
3 | (Segment Asset - Segment Liabilities) | ||||||
Segment Asset | |||||||
Total Segment Asset | |||||||
Un-allocable Assets | null | null | |||||
Net Segment Asset | null | null | |||||
4 | Segment Liabilities | ||||||
Segment Liabilities | |||||||
Total Segment Liabilities | |||||||
Un-allocable Liabilities | null | null | |||||
Net Segment Liabilities | null | null | |||||
Disclosure of notes on segments |
Other Comprehensive Income |
|||
---|---|---|---|
Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
A | Date of start of reporting period | 01-Jan-2025 | 01-Apr-2024 |
B | Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 |
C | Whether results are audited or unaudited | Audited | Audited |
D | Nature of report standalone or consolidated | Consolidated | Consolidated |
Other comprehensive income [Abstract] | |||
1 | Amount of items that will not be reclassified to profit and loss | ||
Total Amount of items that will not be reclassified to profit and loss | |||
2 | Income tax relating to items that will not be reclassified to profit or loss | 152000 | 3213000 |
3 | Amount of items that will be reclassified to profit and loss | ||
Total Amount of items that will be reclassified to profit and loss | |||
4 | Income tax relating to items that will be reclassified to profit or loss | -38000 | -809000 |
5 | Total Other comprehensive income | -114000 | -2404000 |
Cash flow statement, indirect |
||||||
---|---|---|---|---|---|---|
Particulars | Year ended (dd-mm-yyyy) | |||||
A | Date of start of reporting period | 01-Apr-2024 | ||||
B | Date of end of reporting period | 31-Mar-2025 | ||||
C | Whether results are audited or unaudited | Audited | ||||
D | Nature of report standalone or consolidated | Consolidated | ||||
Part I | Blue color marked fields are non-mandatory. | |||||
Statement of cash flows | ||||||
Cash flows from used in operating activities | ||||||
Profit before tax | 277143000 | |||||
Adjustments for reconcile profit (loss) | ||||||
Adjustments for finance costs | 23341000 | |||||
Adjustments for decrease (increase) in inventories | -79666000 | |||||
Adjustments for decrease (increase) in trade receivables, current | 80672000 | |||||
Adjustments for decrease (increase) in trade receivables, non-current | 0 | |||||
Adjustments for decrease (increase) in other current assets | -103694000 | |||||
Adjustments for decrease (increase) in other non-current assets | -16549000 | |||||
Adjustments for other financial assets, non-current | 78189000 | |||||
Adjustments for other financial assets, current | -122541000 | |||||
Adjustments for other bank balances | 0 | |||||
Adjustments for increase (decrease) in trade payables, current | 81316000 | |||||
Adjustments for increase (decrease) in trade payables, non-current | 0 | |||||
Adjustments for increase (decrease) in other current liabilities | -7205000 | |||||
Adjustments for increase (decrease) in other non-current liabilities | 3035000 | |||||
Adjustments for depreciation and amortisation expense | 124511000 | |||||
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0 | |||||
Adjustments for provisions, current | 6721000 | |||||
Adjustments for provisions, non-current | 7756000 | |||||
Adjustments for other financial liabilities, current | 81795000 | |||||
Adjustments for other financial liabilities, non-current | 0 | |||||
Adjustments for unrealised foreign exchange losses gains | 0 | |||||
Adjustments for dividend income | 2318000 | |||||
Adjustments for interest income | 5981000 | |||||
Adjustments for share-based payments | 0 | |||||
Adjustments for fair value losses (gains) | 0 | |||||
Adjustments for undistributed profits of associates | 0 | |||||
Other adjustments for which cash effects are investing or financing cash flow | 0 | |||||
Other adjustments to reconcile profit (loss) | 0 | |||||
Other adjustments for non-cash items | -2404000 | |||||
Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0 | |||||
Total adjustments for reconcile profit (loss) | 146978000 | |||||
Net cash flows from (used in) operations | 424121000 | |||||
Dividends received | 0 | |||||
Interest paid | 0 | |||||
Interest received | 0 | |||||
Income taxes paid (refund) | 65900000 | |||||
Other inflows (outflows) of cash | 0 | |||||
Net cash flows from (used in) operating activities | 358221000 | |||||
Cash flows from used in investing activities | ||||||
Cash flows from losing control of subsidiaries or other businesses | 0 | |||||
Cash flows used in obtaining control of subsidiaries or other businesses | 0 | |||||
Other cash receipts from sales of equity or debt instruments of other entities | 0 | |||||
Other cash payments to acquire equity or debt instruments of other entities | 0 | |||||
Other cash receipts from sales of interests in joint ventures | 0 | |||||
Other cash payments to acquire interests in joint ventures | 0 | |||||
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0 | |||||
Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0 | |||||
Proceeds from sales of property, plant and equipment | 570119000 | |||||
Purchase of property, plant and equipment | 1307715000 | |||||
Proceeds from sales of investment property | 0 | |||||
Purchase of investment property | 0 | |||||
Proceeds from sales of intangible assets | 0 | |||||
Purchase of intangible assets | 0 | |||||
Proceeds from sales of intangible assets under development | 0 | |||||
Purchase of intangible assets under development | 0 | |||||
Proceeds from sales of goodwill | 0 | |||||
Purchase of goodwill | 0 | |||||
Proceeds from biological assets other than bearer plants | 0 | |||||
Purchase of biological assets other than bearer plants | 0 | |||||
Proceeds from government grants | 0 | |||||
Proceeds from sales of other long-term assets | 0 | |||||
Purchase of other long-term assets | 0 | |||||
Cash advances and loans made to other parties | 0 | |||||
Cash receipts from repayment of advances and loans made to other parties | 0 | |||||
Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0 | |||||
Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0 | |||||
Dividends received | 2318000 | |||||
Interest received | 5981000 | |||||
Income taxes paid (refund) | 0 | |||||
Other inflows (outflows) of cash | 383769000 | |||||
Net cash flows from (used in) investing activities | -345528000 | |||||
Cash flows from used in financing activities | ||||||
Proceeds from changes in ownership interests in subsidiaries | 0 | |||||
Payments from changes in ownership interests in subsidiaries | 0 | |||||
Proceeds from issuing shares | 0 | |||||
Proceeds from issuing other equity instruments | 0 | |||||
Payments to acquire or redeem entity's shares | 0 | |||||
Payments of other equity instruments | 0 | |||||
Proceeds from exercise of stock options | 0 | |||||
Proceeds from issuing debentures notes bonds etc | 0 | |||||
Proceeds from borrowings | 0 | |||||
Repayments of borrowings | 0 | |||||
Payments of lease liabilities | 0 | |||||
Dividends paid | 10812000 | |||||
Interest paid | 0 | |||||
Income taxes paid (refund) | 0 | |||||
Other inflows (outflows) of cash | 0 | |||||
Net cash flows from (used in) financing activities | -10812000 | |||||
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 1881000 | |||||
Effect of exchange rate changes on cash and cash equivalents | ||||||
Effect of exchange rate changes on cash and cash equivalents | 0 | |||||
Net increase (decrease) in cash and cash equivalents | 1881000 | |||||
Cash and cash equivalents cash flow statement at beginning of period | 3952000 | |||||
Cash and cash equivalents cash flow statement at end of period | 5833000 |
Details of Impact of Audit Qualification |
|
---|---|
Whether results are audited or unaudited | Audited |
Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
Auditor's opinion | |
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results | Yes |
Sr No. | Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | ||
1 | SHAILESH MANEK & ASSOCIATES | Yes | 31-Jan-2026 |
---|